Researchers have restored vision in mice after stroke. The results, published in Frontiers in Cell and Developmental Biology, showed that...

Driving innovation for patient benefit is a core strategic aim for Discovery Park which aims to be a world class world leading science...

AbbView has announced it has bought the rights for development and commercialisation of RGX-314. This gene therapy product has been...

At a recent meeting, the FDA advised a cautious approach for gene therapy trials. The two day CTGTAC meeting discussed the toxicity...

The FDA has halted testing of BioMarin's AAV based gene therapy drug after liver cancer developed in treated mice. BioMarin's BMN_307...